Dr. Brin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2525 Dupont Dr
Irvine, CA 92612Phone+1 714-246-4429- Is this information wrong?
Education & Training
- Columbia University Neurologic InstituteFellowship, Movement Disorders, 1983 - 1986
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1980 - 1983
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1979 - 1980
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
Certifications & Licensure
- CA State Medical License 2001 - 2025
- NY State Medical License 1980 - 2024
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Deep Brain Stimulation in Treating Patients With Dystonia Start of enrollment: 1997 Sep 01
Publications & Presentations
PubMed
- Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysis.Mitchell F Brin, Koen De Boulle, Steven Liew, Alastair Carruthers, Jean Carruthers, Alexander Rivkin, Yan Wu, Makoto Kawashima, Irina Yushmanova, Terry I Boodhoo, Elis...> ;JAAD International. 2024 Mar 1
- Novel insight into atogepant mechanisms of action in migraine prevention.Melo-Carrillo, A., Strassman, A., Broide, R., Adams, A., Dabruzzo, B., Burstein, R., Brin, M.> ;Brain. 2024 Feb 27
- Botulinum toxin type E associated with reduced itch and pain during wound healing and acute scar formation following excision and linear repair on the forehead: A rand...Murad Alam, Domenico Vitarella, Wajdie Ahmad, Susan Abushakra, Cheri Mao, Mitchell F Brin> ;Journal of the American Academy of Dermatology. 2023 Dec 1
- Join now to see all
Journal Articles
- Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injectionCai BB, Francis J, Brin MF, Broide RS, Neuroscience, 1/1/2017
- Repeated onabotulinumtoxinA treatment of glabellar lines at rest over three treatment cyclesCarruthers A, Carruthers J, Fagien S, Lei X, Kolodziejczyk J, Brin MF, Dermatol.Surg., 1/1/2016
- Impact of cervical dystonia on work productivity: an analysis from a patient registryMolho ES, Stacy M, Gillard P, Charles D, Adler CH, Jankovic J, Schwartz M, Brin MF, Mov Disord.Clin.Pract., 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Effects of onabotulinumtoxinA treatment on the chronic migraine comorbidities of depression, anxiety, sleep and fatigueBrin MF, Manack Adams A, Interagency Botulism Research Coordinating Committee - 54th Annual Meeting, Burlingame, CA, 1/22/2017
- The psychological impact of horizontal frontalis lines, glabellar lines, and lateral canthal lines: qualitative, patient-centered studiesBrin MF, Dayan S, Yoelin SG, De Boulle K, Garcia J, Ferrusi IL, Interagency Botulism Research Coordinating Committee - 54th Annual Meeting, Burlingame, CA, 1/22/2017
- Botulinum neurotoxin type A�cleaved SNAP25 is confined to primary motor neurons and expressed on the plasma membrane following intramuscular toxin injectionBroide R, Cai B, Francis J, Brin MF, Society for Neuroscience - 46th Annual Meeting; International Neurotoxin Association - 3rd Conference (TOXINS), San Diego, CA, 2016; Madrid, Spain, 2017, 1/18/2017
- Join now to see all
Other
- The Role of Chemodenervation in Spasticity Management (Videotape)Brin MF, O'Brien CF, Gormley ME, McGuire J, Blazer J, WE MOVE
www.wemove.org
New York, NY - 1/1/2000 - New Advances in the Management of Spasticity and Muscle Overactivity (CD Rom)Esquenazi A, Mayer N, Professional Postgraduate Services
Knoxville, TN - 1/1/2000 - Advances in dystonia: Classification, genetics and therapeuticsBrin MF, Neuroscience Year: Supplement to the Encyclopedia of Neuroscience
1/1/1999 - Join now to see all
Press Mentions
- AbbVie Announces Late-Breaking Results from Phase 2 Exploratory NOVA Trial of Novel Investigational Neurotoxin AGN-151607 for the Prevention of Postoperative Atrial Fibrillation in Cardiac Surgery PatientsNovember 9th, 2022
- Botox Approved to Treat Spasticity in 8 New Arm, Hand MusclesAugust 2nd, 2021
- AbbVie Adds to the Botox War Chest with a 12th FDA Approval — but Competition Is Fast ApproachingFebruary 10th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- UCI HealthOrange, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: